Answers are grounded in this paper and cite their sources.
Respiratory syncytial virus is a major cause of lower respiratory tract infection morbidity and mortality in children globally, causing 3·2–3·6 million hospitalisations and more than 100 000 deaths annually in children younger than 5 years, 99% of which occur in low-income and middle-income countries (LMICs).1 Despite being identified 65 years ago, at the same time as poliovirus, there is no widely available and affordable preventive strategy for respiratory syncytial virus.
No takes yet. Share an insight, caveat, or question.
Carbonell‐Estrany et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: